Ashvattha Therapeutics

Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.

Domain

avttx.com

Employees

11-50

Last Funding

$50.0M

Founded

2014

Frequently Asked Questions

What technologies does Ashvattha Therapeutics use?+

Ashvattha Therapeutics uses 14 technologies including Elementor, GDPR Cookie Consent Plugin by Webtoffee, GeneratePress.

What industry is Ashvattha Therapeutics in?+

Ashvattha Therapeutics operates in the Biotechnology industry.

Where is Ashvattha Therapeutics based?+

Ashvattha Therapeutics is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026